The COAPT Trial is a clinical trial designed to study the safety and effectiveness of the MitraClip® device in heart failure patients who have functional mitral regurgitation (MR) and are considered extremely high-risk for surgery.

We welcome you to learn more about the trial, patient eligibility and participating trial sites.

About the COAPT Trial »

Introducing the COAPT Trial Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for Extremely High-Surgical-Risk Patients